Dermatology
Sustained Relief for Prurigo Nodularis: Nemolizumab Shows Durable Results at Two Years
Prurigo nodularis (PN), long regarded as one of the most
July 3, 2025
Prurigo nodularis (PN), long regarded as one of the most
Hair loss continues to be a significant concern for many
The FDA has approved Dupixent® (dupilumab) as the first and
For many patients, skin disease isn’t just skin deep—it can
Dermatology is experiencing a notable shift: younger generations, specifically Millennials
Melanoma remains one of the most aggressive forms of skin
As the role of lifestyle factors in cancer outcomes continues
In a significant development for psoriasis treatment, the U.S. Food
Recent findings indicate a significant increase in musculoskeletal injuries (MSIs)
Dermatologic care is in the process of a significant advancement
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2025, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
